As demand for weight loss and diabetes drugs surges, Eli Lilly and Novo Nordisk dominate the market. Discover the challenges, competition, and future of this booming industry.
Barington Capital is demanding a complete board overhaul at Victoria's Secret, citing significant shareholder losses and a need for revitalization. The hedge fund believes the company's beauty division holds great potential and seeks to end its current defensive strategies.
Stocks are soaring as US-China trade talks show signs of easing tensions. Investors are optimistic, but concrete announcements are still awaited. Can these discussions lead to sustained market growth?
Goldman Sachs predicts a significant surge in Chinese equities fueled by optimism around technological advancements and market performance, with the MSCI China Index expected to rise by 16% in the next 12 months.
